Summary
Biogen Inc. (BIIB) has announced the successful completion of its debt exchange and cash tender offers for its 5.200% Senior Notes due 2045 (Old Notes). The company exchanged approximately $624.6 million of Old Notes for new 3.250% Senior Notes due 2051 (New Notes) and cash, while also repurchasing approximately $8.9 million of Old Notes for cash. This proactive debt management signifies Biogen's efforts to optimize its capital structure by lowering its interest expense and extending its debt maturity profile.
Key Highlights
- 1Biogen completed an exchange offer for its 5.200% Senior Notes due 2045, issuing new 3.250% Senior Notes due 2051.
- 2Approximately $624.6 million of Old Notes were exchanged for New Notes and cash.
- 3An additional $8.9 million of Old Notes were repurchased for cash.
- 4The New Notes carry a lower interest rate of 3.250% compared to the Old Notes' 5.200%.
- 5The New Notes have a maturity date of February 15, 2051, extending the company's debt maturity.
- 6Biogen entered into a Registration Rights Agreement to register the New Notes for resale or exchange, ensuring liquidity for investors.
- 7The offers were conducted privately and not registered under the Securities Act of 1933.
Frequently Asked Questions
The primary financial implication is a reduction in Biogen's interest expense. By exchanging higher-coupon 5.200% Senior Notes for lower-coupon 3.250% Senior Notes, the company will save on its annual interest payments. Additionally, extending the maturity date to 2051 provides longer-term financial stability.
After the exchange and cash offers, the aggregate principal amount of $1,116,526,000.00 of the Old Notes remains outstanding.
The New Notes were issued privately and are not registered under the Securities Act of 1933. However, Biogen has entered into a Registration Rights Agreement to file an exchange offer registration statement for registered notes (Exchange Notes) or a shelf registration statement, which will provide liquidity and allow for resales under certain conditions.
The New Notes bear interest at a rate of 3.250% per year, mature on February 15, 2051, and interest is payable semi-annually on February 15 and August 15. They are senior unsecured obligations, include redemption provisions at Biogen's option, and contain a change-of-control provision requiring a potential repurchase at 101% of the principal amount under specified circumstances.